Hyponatremia: A clinical approach


Cite item

Full Text

Abstract

Hyponatremia is the most common electrolyte metabolic abnormality in clinical practice. The unfavorable course of many diseases is associated with hyponatremia. Acute severe hyponatremia is life-threatening because cerebral edema may develop. Less obvious chronic hyponatremia increases the risk of balance problems, falls and fractures, especially in elderly patients. In any occasion, hyponatremia should not be now regarded only as a laboratory phenomenon in critically ill patients, but it necessitates a thorough clinical analysis of each individual case and appropriate therapy. The paper presents approaches to diagnosing and treating hyponatremia in various clinical situations.

About the authors

D Yu Shchekochikhin

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

N L Kozlovskaya

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

F Yu Kopylov

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

A L Syrkin

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

E M Shilov

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

References

  1. Schrier RW. Body Water Homeostasis: Clinical Disorders of Urinary Dilution and Concentration. Journal of American Society of Nephrology. 2006;17:1820-1832. https://doi.org/10.1681/ASN.2006030240
  2. Наточин Ю.В. Вазопрессин: механизмы действия и клиническая физиология. Проблемыэндокринологии. 2003;2:43-50.
  3. Наточин Ю.В., Шахматова Е.И., Канашкина Т.А. Роль V1- и V2-рецепторов в механизме физиологического парадокса — увеличение реабсорбции осмотически свободной воды на фоне повышения диуреза. Российскийфизиологическийжурнал. 2006;10:1228-1238.
  4. Nielsen S, Frokiaer J, Marples D, Kwon TH, Knepper AP. Aquaporins in the kidney: from molecules to medicine. Physiological Reviews. 2002;82(1):205-244. https://doi.org/10.1152/physrev.00024.2001
  5. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clinica Chimica Acta. 2003;337:169-172. https://doi.org/10.1016/j.cccn.2003.08.001
  6. Hoorn E, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrology Dialysis Transplantation. 2006;21(1):70-76. https://doi.org/10.1093/ndt/gfi082
  7. Ayus JC, Achinger SG, Arieff A. Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia. American Journal of Physiology — Renal Physiology. 2008;295(3):F619-F624. https://doi.org/10.1152/ajprenal.00502.2007
  8. Pasantes-Morales H, Franco R, Ordaz B, Ochoa LD. Mechanisms counteracting swelling in brain cells during hyponatremia. Archives of Medical Research. 2002;33(3):237-244. https://doi.org/10.1016/S0188-4409(02)00353-3
  9. Wald R, Jaber BL, Price LL, Upadhyay A, Madias, NE. Impact of Hospital-Associated Hyponatremia on Selected Outcomes. Archives of Internal Medicine. 2010;170(3):294-302. https://doi.org/10.1001/archinternmed.2009.513
  10. Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: do patients die from or with hyponatremia? Clinical Journal of the American Society of Nephrology. 2011;6(5):960-965. https://doi.org/10.2215/CJN.10101110
  11. Chen YC, Cadnapaphornchai MA, Yang J, Summer SN, Falk S, Li C, Wang W, Schrier RW. Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism. AJP: Renal Physiology. 2005;289(4):F672-F678. https://doi.org/10.1152/ajprenal.00384.2004
  12. Warner MH, Holding S, Kilpatrick ES. The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study. Clinical Endocrinology. 2006;64(5):598-599. https://doi.org/10.1111/j.1365-2265.2006.02489.x
  13. Schrier RW, Sharma S, Shchekochikhin D. Hyponatraemia: more than just a marker of disease severity? Nature Reviews Nephrology. 2013,9(1):37-50. https://doi.org/10.1038/nrneph.2012.246
  14. Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis. New England Journal of Medicine. 2005;352(18):1884-1890. https://doi.org/10.1056/NEJM200508043530520
  15. Diringer MN, Zazulia AR. Hyponatremia in neurologic patients: consequences and approaches to treatment. The Neurologist. 2006;12(3):117-126. https://doi.org/10.1097/01.nrl.0000215741.01699.77
  16. Berl T, Schrier R: Disorders of water metabolism. In: Schrier R, ed. Renal and Electrolyte Disorders. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2010:1-45.
  17. Burgess C, O’Donohoe A, Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. European Psychiatry. 2000;15(5):287-294. https://doi.org/10.1016/s0924-9338(00)00396-5
  18. Gill G, Huda B, Boyd A, Skagen K, Wile D, Watson I, van Heyningen C. Characteristics and mortality of severe hyponatraemia—a hospital-based study. Clinical Endocrinology. 2006;65:246-249. https://doi.org/10.1111/j.1365-2265.2006.02583.x
  19. Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen A. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. American Journal of Kidney Diseases. 2012;59(2):222-228. https://doi.org/10.1053/j.ajkd.2011.08.029
  20. Onitilo AA, Kio E, Doi SAR. Tumor-Related Hyponatremia. Clinical Medicine & Research. 2007;5(4):228-237. https://doi.org/10.3121/cmr.2007.762
  21. Sorensen JB, Andersen MK, Hansen HH. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. Journal of Internal Medicine. 2005;238:97-110. https://doi.org/10.1111/j.1365-2796.1995.tb00907.x
  22. Hamdi T, Latta S, Jallad B, Kheir F, Alhosaini MN, Patel A. Cisplatin-induced renal salt wasting syndrome. Southern Medical Journal. 2010;103(8):793-799. https://doi.org/10.1097/smj.0b013e3181e63682
  23. Issa MM, Young MR, Bullock AR, Bouet R, Petros JA. Dilutional hyponatremia of TURP syndrome: a historical event in the 21st century. Urology. 2004;64:298-301. https://doi.org/10.1016/j.urology.2004.03.023
  24. Miller M, Hecker MS, Friedlander DA. Apparent idiopathic hyponatremia in an ambulatory geriatric population. Journal of the American Geriatrics Society. 1996;44(4):404-408. https://doi.org/10.1111/j.1532-5415.1996.tb06410.x
  25. Renneborg B, Musch W, Vandemergel X, Manto M, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. The American Journal of Medicine. 2006;71e1-71.e8. https://doi.org/10.1016/j.amjmed.2005.09.026
  26. Hoorn EJ, Rivadeneira F, van Meurs JB, et al. Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. Journal of Bone and Mineral Research. 2011;26(8):1822-1828. https://doi.org/10.1002/jbmr.380
  27. Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia-induced osteoporosis. Journal of Bone and Mineral Research. 2009;25(3): 554-563. https://doi.org/10.1359/jbmr.090827
  28. Barsony J, Sugimura Y, Verbalis JF. Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss. Journal of Biological Chemistry. 2011;286(12): 10864-75. https://doi.org/10.1074/jbc.m110.155002
  29. Speedy DB, Noakes TD, Rogers IR, et al. Hyponatremia in ultradistance triathletes. Medicine & Science in Sports & Exercise. 1999; 31(6):809-815. https://doi.org/10.1097/00005768-199906000-00008
  30. Almond CS, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Boston Marathon. New England Journal of Medicine. 2005;352(15):1550-1556. https://doi.org/10.1056/nejmoa043901
  31. Knechtle B, Knechtle P, Rosemann T. Low prevalence of exercise-associated hyponatremia in male 100 km ultra-marathon runners in Switzerland. European Journal of Applied Physiology. 2011;111(6):1007-1016. https://doi.org/10.1007/s00421-010-1729-7
  32. Kipps C, Sharma S, Pedoe DT. The incidence of exercise-associated hyponatraemia in the London marathon. British Journal of Sports Medicine. 2011;45(1):14-19. https://doi.org/10.1136/bjsm.2009.059535
  33. Siegel AJ, Verbalis JG, Clement S, et al. Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. The American Journal of Medicine. 2007;120(5):461.e11-e17. https://doi.org/10.1016/j.amjmed.2006.10.027
  34. Shchekochikhin DY, Schrier RW, Lindenfeld J, Price LL, Jaber BL, Madias NE. Outcome differences in community- versus hospital-acquired hyponatremia in patients with a diagnosis of heart failure. Circulation: Heart Failure. 2013;6(3):379-386. https://doi.org/10.1161/circheartfailure.112.000106
  35. Bettari L, Fiuzat M, Shaw LK et al. Hyponatremia and long-term outcomes in chronic heart failure-an observational study from the Duke Databank for Cardiovascular Diseases. Journal of Cardiac Failure. 2012;18(1):74-81. https://doi.org/10.1016/j.cardfail.2011.09.005
  36. Allen LA, Gheorghiade M, Reid KJ, et al. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circulation: Cardiovascular Quality and Outcomes. 2011;4(4):389-398. https://doi.org/10.1161/circoutcomes.110.958009
  37. Abraham WT. Hormones and hemodynamics in heart failure. New England Journal of Medicine. 1999;19;341(8):577-585. https://doi.org/10.1056/nejm199908193410806
  38. Schrier RW. Body fluid regulation in health and disease: A unifying hypothesis. Annals of Internal Medicine. 1990;113:155-159. https://doi.org/10.7326/0003-4819-113-2-155
  39. Forfia PR, Mathai SC, Fisher MR, et al. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine. 2008;177(12):1364-1369. https://doi.org/10.1164/rccm.200712-1876oc
  40. Scherz N, Labarère J, Méan M, Ibrahim SA, Fine MJ, Aujesky D. Prognostic importance of hyponatremia in patients with acute pulmonary embolism. American Journal of Respiratory and Critical Care Medicine. 2010;182(9):1178-1183. https://doi.org/10.1164/rccm.201003-0481oc
  41. Crestanello JA, Phillips G, Firstenberg MS, et al. Preoperative hyponatremia predicts outcomes after cardiac surgery. Journal of Surgical Research. 2013;181(1):60-66. https://doi.org/10.1016/j.jss.2012.06.004
  42. Gines P, Schrier RW. Renal failure in cirrhosis. New England Journal of Medicine. 2009;24;361(13):1279-1290. https://doi.org/0.1056/nejmra0809139
  43. Gines P, Berl T, Bernardi M, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology. 1998;28(3):851-864. https://doi.org/10.1002/hep.510280337
  44. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. New England Journal of Medicine. 1998;339:533-541. https://doi.org/10.1056/nejm199808203390807
  45. Guevara M, Baccaro ME, Rнos J et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver International. 2010;30(8):1137-1142. https://doi.org/10.1111/j.1478-3231.2010.02293.x
  46. Sola E, Watson H, Guevara M, et al. Factors related to quality of life in patients with cirrhosis and ascites. Relevance of serum sodium concentration and leg edema. Journal of Hepatology. 2012;57(6):1199-1206. https://doi.org/10.1016/j.jhep.2012.07.020
  47. Hackworth WA, Heuman DM, Sanyal AJ, et al. Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver International. 2009;29(7):1071-1077. https://doi.org/10.1111/j.1478-3231.2009.01982.x
  48. Dawwas MF, Lewsey JD, Neuberger JM, et al . The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transplantation. 2007;13:1115-1124. https://doi.org/10.1002/lt.21154
  49. Yun BC, Kim WR, Benson JT, et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology. 2009;49:1610-1615. https://doi.org/10.1002/hep.22846
  50. Fenske W, Maier SK, Blechschmidt A, Allolio B, Störk S. Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. The American Journal of Medicine. 2010;123(7):652-657. https://doi.org/10.1016/j.amjmed.2010.01.013
  51. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. New England Journal of Medicine. 2007;356(20):2064-2072. https://doi.org/10.1056/nejmcp066837
  52. Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clinical Journal of the American Society of Nephrology. 2008;3(4): 1175-1184. https://doi.org/10.2215/cjn.04431007
  53. Fenske W, Störk S, Koschker AC, et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. The Journal of Clinical Endocrinology & Metabolism. 2008;93(8):2991-2997. https://doi.org/10.1210/jc.2008-0330
  54. Fenske W, Störk S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B. Copeptin in the differential diagnosis of hyponatremia. The Journal of Clinical Endocrinology & Metabolism. 2009; 94(1):123-129. https://doi.org/10.1210/jc.2008-1426
  55. Moritz ML, Ayus JC. 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metabolic Brain Disease. 2010;25(1):91-96. https://doi.org/10.1007/s11011-010-9173-2
  56. Koenig MA, Bryan M, Lewin JL 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13):1023-1029. https://doi.org/10.1212/01.wnl.0000304042.05557.60
  57. Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. Journal of the American Society of Nephrology. 1994;4(8):1522-1530.
  58. Cluitmans FH, Meinders AE. Management of severe hyponatremia: rapid or slow correction? The American Journal of Medicine. 1990;88(2):161-166. https://doi.org/10.1016/0002-9343(90)90467-r
  59. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. The American Journal of Medicine. 2007; 120(11):S1-21. https://doi.org/10.1016/j.amjmed.2007.09.001
  60. Miller PD, Linas SL, Schrier RW. Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. JAMA. 1980;243:2513-2515. https://doi.org/10.1001/jama.243.24.2513
  61. Jaal J, Jõgi T, Altraja A. Small Cell Lung Cancer Patient with Profound Hyponatremia and Acute Neurological Symptoms: An Effective Treatment with Fludrocortisone. Case Reports in Oncological Medicine. 2015:1-4. https://doi.org/10.1155/2015/286029
  62. Decaux G, Andres C, Gankam Kengne F, Soupart A. Treatment of euvolemic hyponatremia in the intensive care unit by urea. Critical Care. 2010;14(5):R184. https://doi.org/10.1186/cc9292
  63. Soupart A, Coffernils M, Couturier B, Gankam-Kengne F, Decaux G. Efficacy and Tolerance of Urea Compared with Vaptans for Long-Term Treatment of Patients with SIADH. Clinical Journal of the American Society of Nephrology. 2012;7(5):742-747. https://doi.org/10.2215/cjn.06990711
  64. Verbalis JG, Zeltser D, Smith N, Barve A, Andoh M. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study. Clinical Endocrinology. 2008;69(1):159-168. https://doi.org/10.1111/j.1365-2265.2007.03149.x
  65. Berl T, Quittnat-Pelletier F, Verbalis JG, et al. SALTWATER Investigators. Oral tolvaptan is safe and effective in chronic hyponatremia. Journal of the American Society of Nephrology. 2010;21(4): 705-712. https://doi.org/10.1681/asn.2009080857

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies